Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arteris (AIP) Cash & Current Investments (2023 - 2025)

Arteris' Cash & Current Investments history spans 3 years, with the latest figure at $54.6 million for Q4 2025.

  • For Q4 2025, Cash & Current Investments rose 24.54% year-over-year to $54.6 million; the TTM value through Dec 2025 reached $54.6 million, up 24.54%, while the annual FY2025 figure was $54.6 million, 24.54% up from the prior year.
  • Cash & Current Investments reached $54.6 million in Q4 2025 per AIP's latest filing, up from $39.0 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $60.9 million in Q1 2023 to a low of $38.0 million in Q2 2025.
  • Average Cash & Current Investments over 3 years is $46.7 million, with a median of $45.3 million recorded in 2024.
  • Peak YoY movement for Cash & Current Investments: dropped 26.45% in 2024, then rose 24.54% in 2025.
  • A 3-year view of Cash & Current Investments shows it stood at $41.2 million in 2023, then increased by 6.48% to $43.8 million in 2024, then increased by 24.54% to $54.6 million in 2025.
  • Per Business Quant, the three most recent readings for AIP's Cash & Current Investments are $54.6 million (Q4 2025), $39.0 million (Q3 2025), and $38.0 million (Q2 2025).